Genetic Analysis Second Quarter 2025 Earnings: kr0.014 loss per share (vs kr0.11 loss in 2Q 2024)
Genetic Analysis (FRA:8V8) Second Quarter 2025 Results Key Financial Results Revenue: kr7.15m (up 44% from 2Q 2024). Net loss:
recent post
-
Feb 07 2026 -
Feb 07 2026
-
Feb 07 2026
-
Feb 07 2026
-
Feb 07 2026
Metaplanet Shares Jump 6% as Company Unveils Major Financing Moves
Metaplanet Inc. (3350) rose 5.7% on Wednesday after the Tokyo-based company said it plans to sell shares to foreign
Stock Analysis | Mastercard Outlook
Market Snapshot Headline Takeaway: Mastercard (MA) is in a state of technical neutrality, with bearish signals outweighing bullish ones,
Stock Analysis | Automatic Data Processing Outlook
Market Snapshot Headline takeaway: ADP shows a modest price rise but faces a technically weak chart with more bearish
Carl Zeiss Meditec AG’s (ETR:AFX) Share Price Matching Investor Opinion
Carl Zeiss Meditec AG’s (ETR:AFX) price-to-earnings (or “P/E”) ratio of 25.3x might make it look like a sell right
Stock Analysis | Rockwell Automation Outlook
Market Snapshot: Cautious Optimism with a Technical Dilemma Takeaway: Rockwell Automation (ROK) is facing a mixed technical landscape with
Stock Analysis | CDW Outlook
Market Snapshot Takeaway: CDW is currently showing a modest price rise of 1.29%, but technical indicators remain bearish while
Stock Analysis | Bio-Techne Outlook
Bio-Techne Outlook – A Divergent Market Picture Emerges Market Snapshot: The stock of Bio-Techne (TECH) is currently trending upward
Stock Analysis | Pepsico Outlook
Market Snapshot Headline Takeaway: Pepsico faces a mixed market outlook with weak technicals but strong fundamentals. Stance: Caution advised.
Stock Analysis | PPL Outlook
Market Snapshot Takeaway: PPL is under pressure technically with a score of 3.61, suggesting weak momentum and a bearish